Heron Therapeuti
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $36,024 | $34,670 | $34,233 | $31,434 |
Gross Profit | 25,506 | 26,226 | 24,348 | 13,226 |
EBITDA | -5,804 | -4,109 | -9,505 | -24,202 |
EBIT | -6,445 | -4,798 | -10,220 | -24,929 |
Net Income | -9,235 | -3,160 | -10,724 | -25,008 |
Net Change In Cash | 36,024 | 34,670 | 34,233 | 31,434 |
Free Cash Flow | -5,241 | -9,516 | 2,205 | -9,972 |
Cash | 18,386 | 20,450 | 28,677 | 34,859 |
Basic Shares | 152,305 | 151,199 | 150,285 | 144,990 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $127,044 | $107,672 | $86,346 | $88,638 |
Gross Profit | 61,939 | 52,798 | 40,325 | 52,449 |
EBITDA | -107,716 | -171,769 | -214,807 | -225,316 |
EBIT | -110,615 | -174,658 | -217,828 | -228,163 |
Net Income | -110,559 | -134,516 | -217,662 | -224,431 |
Net Change In Cash | 127,044 | 107,672 | 86,346 | 88,638 |
Cost of Revenue | -14,597 | 33,240 | ||
Free Cash Flow | -60,334 | -148,737 | -206,376 | -191,633 |
Cash | 28,677 | 15,364 | 90,541 | 105,138 |
Basic Shares | 138,135 | 108,876 | 98,471 | 90,774 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.06 |
2024-03-31 | -$0.02 |
2023-12-31 | -$0.07 |
2023-09-30 | -$0.17 |
